4Filed Aug 12, 8:00 PM ET

BeOne (ONC) SVP Lee Chan Henry Exercises Options and Sells Shares

$ONC · BeOne Medicines Ltd.

Research Summary

AI-generated summary of this SEC filing

Updated

BeOne (ONC) SVP Lee Chan Henry Exercises Options and Sells Shares

What Happened
Lee Chan Henry, Senior Vice President and General Counsel of BeOne Medicines (ONC), executed multiple option exercises on August 11, 2026 and sold 2,666 shares in the open market the same day. He acquired 812 shares at $194.47 ($157,910), 1,058 shares at $213.32 ($225,693), and 796 shares at $159.03 ($126,588) — a total cash exercise of $510,191 for 2,666 shares. He then sold those 2,666 shares at $360.00 each for total gross proceeds of $959,760. The Form 4 also reports disposals of 10,556, 13,754 and 10,348 shares at $0 (listed as derivative dispositions).

Key Details

  • Transaction date: August 11, 2026; Form 4 filed August 13, 2026 (timely — within required reporting window).
  • Open-market sale: 2,666 shares @ $360.00 = $959,760; sale effected under a Rule 10b5-1 plan (Footnote F2).
  • Option exercises (acquired): 812 @ $194.47 ($157,910); 1,058 @ $213.32 ($225,693); 796 @ $159.03 ($126,588). Total exercised-acquired shares = 2,666.
  • Derivative dispositions (reported at $0): 10,556; 13,754; 10,348 shares — shown as disposals of derivative securities in the filing.
  • Footnotes of note: F1 — each American Depositary Share (ADS) represents 13 ordinary shares; F3 — option counts/prices are represented in ordinary shares; F4–F6 — vesting schedules for related awards (multi-year vesting with acceleration on certain terminations).
  • Shares owned after the transactions: not specified in the information provided.

Context

  • This is an option exercise combined with an immediate sale of the shares acquired (the numbers acquired equal the shares sold). The filing also shows zero-dollar derivative dispositions — commonly used to indicate shares were surrendered/used in relation to exercises or tax withholding; the filing records these as dispositions but does not explain the mechanics.
  • The sale was executed under a pre-established Rule 10b5-1 trading plan (per F2), which is a common method executives use to schedule sales and reduces the implication of opportunistic timing.
  • This report is transactional and factual; it does not state the insider’s motivations.